Published in N Engl J Med on August 17, 2000
Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease | NCT00408525
Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci U S A (2009) 9.19
Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement (2005) 7.90
Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron (2009) 7.02
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci (2011) 5.64
Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res (2008) 5.29
Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol (2004) 4.89
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol (2013) 4.16
Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology (2005) 3.90
Retracted Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease. Nature (2013) 3.35
fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology (2005) 3.22
Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study. JAMA Neurol (2014) 3.19
Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease. Proc Natl Acad Sci U S A (2005) 3.15
Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol (2010) 3.08
Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease. Nat Neurosci (2010) 2.99
Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron (2012) 2.89
Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments. J Alzheimers Dis (2011) 2.78
Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med (2010) 2.77
Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci U S A (2005) 2.68
Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation. Proc Natl Acad Sci U S A (2008) 2.65
High-resolution structural and functional MRI of hippocampal CA3 and dentate gyrus in patients with amnestic Mild Cognitive Impairment. Neuroimage (2010) 2.62
fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J Neurol Neurosurg Psychiatry (2003) 2.49
Effect of APOE ε4 status on intrinsic network connectivity in cognitively normal elderly subjects. Arch Neurol (2011) 2.40
Pattern separation deficits associated with increased hippocampal CA3 and dentate gyrus activity in nondemented older adults. Hippocampus (2010) 2.39
A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. Nat Med (2009) 2.37
The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation. J Neurosci (2006) 2.34
Multi-modal imaging predicts memory performance in normal aging and cognitive decline. Neurobiol Aging (2008) 2.31
The cognitive neuroscience of ageing. Nat Rev Neurosci (2012) 2.28
Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology (2010) 2.25
Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible. Biomark Med (2010) 2.17
Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology (2003) 2.10
Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype. Proc Natl Acad Sci U S A (2007) 1.91
Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease. J Int Neuropsychol Soc (2006) 1.90
Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups. Neuroimage (2009) 1.89
Activation of brain regions vulnerable to Alzheimer's disease: the effect of mild cognitive impairment. Neurobiol Aging (2005) 1.88
Familial risk for Alzheimer's disease alters fMRI activation patterns. Brain (2006) 1.86
Cerebral perfusion and oxygenation differences in Alzheimer's disease risk. Neurobiol Aging (2008) 1.82
Neural function, injury, and stroke subtype predict treatment gains after stroke. Ann Neurol (2014) 1.82
Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. JAMA Neurol (2013) 1.75
Functional reorganisation of memory after traumatic brain injury: a study with H(2)(15)0 positron emission tomography. J Neurol Neurosurg Psychiatry (2002) 1.74
Machine learning and radiology. Med Image Anal (2012) 1.72
Abnormal cortical networks in mild cognitive impairment and Alzheimer's disease. PLoS Comput Biol (2010) 1.72
A Bayesian hierarchical framework for spatial modeling of fMRI data. Neuroimage (2007) 1.69
β-Amyloid affects frontal and posterior brain networks in normal aging. Neuroimage (2010) 1.68
Association of the SerCys DISC1 polymorphism with human hippocampal formation gray matter and function during memory encoding. Eur J Neurosci (2008) 1.67
Temporal lobe functional activity and connectivity in young adult APOE varepsilon4 carriers. Alzheimers Dement (2009) 1.60
Brain network local interconnectivity loss in aging APOE-4 allele carriers. Proc Natl Acad Sci U S A (2011) 1.60
Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiol Aging (2006) 1.58
Large-scale functional brain network abnormalities in Alzheimer's disease: insights from functional neuroimaging. Behav Neurol (2009) 1.58
Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease. NeuroRx (2005) 1.58
Apolipoprotein E, not fibrillar β-amyloid, reduces cerebral glucose metabolism in normal aging. J Neurosci (2012) 1.58
The relationship between aging, performance, and the neural correlates of successful memory encoding. Cereb Cortex (2008) 1.56
Vulnerable neural systems and the borderland of brain aging and neurodegeneration. Neuron (2013) 1.54
Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Trends Neurosci (2011) 1.51
Current and future uses of neuroimaging for cognitively impaired patients. Lancet Neurol (2008) 1.49
The influence of parental history of Alzheimer's disease and apolipoprotein E epsilon4 on the BOLD signal during recognition memory. Brain (2008) 1.47
BDNF val66met polymorphism influences motor system function in the human brain. Cereb Cortex (2009) 1.46
Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease. Brain Pathol (2012) 1.45
Hippocampal hyperactivation in presymptomatic familial Alzheimer's disease. Ann Neurol (2010) 1.45
White matter is altered with parental family history of Alzheimer's disease. Alzheimers Dement (2010) 1.45
Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: functional magnetic resonance imaging evidence for cognitive reserve. Brain (2009) 1.45
Riluzole rescues glutamate alterations, cognitive deficits, and tau pathology associated with P301L tau expression. J Neurochem (2015) 1.44
New therapeutic targets in the neurovascular pathway in Alzheimer's disease. Neurotherapeutics (2008) 1.44
Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: a cross-sectional study. BMC Med (2006) 1.42
Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults. J Neurosci (2011) 1.41
Treatment strategies targeting excess hippocampal activity benefit aged rats with cognitive impairment. Neuropsychopharmacology (2009) 1.39
Brain imaging in Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.37
APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging. Annu Rev Clin Psychol (2009) 1.37
Attention biases, anxiety, and development: toward or away from threats or rewards? Depress Anxiety (2011) 1.37
PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease. Neurotherapeutics (2008) 1.36
Exercise improves cognition and hippocampal plasticity in APOE epsilon4 mice. Alzheimers Dement (2009) 1.36
Neuropsychological contributions to the early identification of Alzheimer's disease. Neuropsychol Rev (2008) 1.35
Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play. Radiology (2012) 1.34
Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.32
Event-related functional magnetic resonance imaging investigation of executive control in very old individuals with mild cognitive impairment. Biol Psychiatry (2005) 1.28
Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection. Annu Rev Clin Psychol (2013) 1.28
Aβ Deposition in aging is associated with increases in brain activation during successful memory encoding. Cereb Cortex (2011) 1.26
The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI). Front Aging Neurosci (2013) 1.26
Hippocampal activation in patients with mild cognitive impairment is necessary for successful memory encoding. J Neurol Neurosurg Psychiatry (2007) 1.25
Decline in verbal memory during preclinical Alzheimer's disease: examination of the effect of APOE genotype. J Int Neuropsychol Soc (2002) 1.21
Self-administered screening for mild cognitive impairment: initial validation of a computerized test battery. J Neuropsychiatry Clin Neurosci (2005) 1.20
Neurovascular function in Alzheimer's disease patients and experimental models. J Cereb Blood Flow Metab (2011) 1.18
Semantic memory activation in amnestic mild cognitive impairment. Brain (2009) 1.18
Evaluation of memory impairment in aging adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiotherapy. J Natl Cancer Inst (2013) 1.17
Reduced hippocampal volume in healthy young ApoE4 carriers: an MRI study. PLoS One (2012) 1.17
Interactive effects of physical activity and APOE-ε4 on BOLD semantic memory activation in healthy elders. Neuroimage (2010) 1.14
Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer disease. Alzheimer Dis Assoc Disord (2010) 1.14
Synchronized brain activity and neurocognitive function in patients with low-grade glioma: a magnetoencephalography study. Neuro Oncol (2008) 1.14
Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia. CMAJ (2008) 1.13
Prominent hippocampal CA3 gene expression profile in neurocognitive aging. Neurobiol Aging (2009) 1.12
Prediction of cognitive decline in healthy older adults using fMRI. J Alzheimers Dis (2010) 1.12
Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease. Neuropsychol Rev (2007) 1.11
Selective GABA(A) α5 positive allosteric modulators improve cognitive function in aged rats with memory impairment. Neuropharmacology (2012) 1.10
Functional magnetic resonance imaging. J Neurol Neurosurg Psychiatry (2004) 1.10
FMRI of working memory in patients with mild cognitive impairment and probable Alzheimer's disease. Eur Radiol (2005) 1.09
APOE genotype and cerebral blood flow in healthy young individuals. JAMA (2003) 1.09
Effect of Alzheimer disease risk on brain function during self-appraisal in healthy middle-aged adults. Arch Gen Psychiatry (2007) 1.09
Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression. Brain (2015) 1.07
Effect of acupuncture in mild cognitive impairment and Alzheimer disease: a functional MRI study. PLoS One (2012) 1.06
Exercise, APOE, and working memory: MEG and behavioral evidence for benefit of exercise in epsilon4 carriers. Biol Psychol (2008) 1.05
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (1993) 33.32
Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci U S A (1992) 16.64
Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. Proc Natl Acad Sci U S A (1992) 14.96
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology (1993) 14.54
Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med (1996) 10.60
Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol (1999) 10.45
Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc Natl Acad Sci U S A (1986) 9.31
Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology (1974) 7.34
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet (1994) 7.07
Automated image registration: II. Intersubject validation of linear and nonlinear models. J Comput Assist Tomogr (1998) 6.75
Parametric analysis of fMRI data using linear systems methods. Neuroimage (1997) 6.65
Practice-related changes in human brain functional anatomy during nonmotor learning. Cereb Cortex (1994) 4.79
Brain activation modulated by sentence comprehension. Science (1996) 4.19
Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA (1995) 4.02
Age-related changes in cortical blood flow activation during visual processing of faces and location. J Neurosci (1994) 2.92
Apolipoprotein E genotyping in Alzheimer's disease. National Institute on Aging/Alzheimer's Association Working Group. Lancet (1996) 2.87
Separate neural bases of two fundamental memory processes in the human medial temporal lobe. Science (1997) 2.71
Activation of the prefrontal cortex in a nonspatial working memory task with functional MRI. Hum Brain Mapp (1994) 2.51
The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults. J Am Geriatr Soc (1998) 2.03
Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology (1999) 1.78
Stability, repeatability, and the expression of signal magnitude in functional magnetic resonance imaging. J Magn Reson Imaging (1999) 1.67
Diffusion weighted fMRI at 1.5 T. Magn Reson Med (1996) 1.41
Hippocampal formation size predicts declining memory performance in normal aging. Neurology (1996) 1.33
Hippocampal neuron loss and memory scores before and after temporal lobe surgery for epilepsy. Arch Neurol (1993) 1.32
Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET. Am J Psychiatry (1996) 1.23
Localization of brain function using magnetic resonance imaging. Trends Neurosci (1994) 1.17
Activation of cerebral blood flow during a visuoperceptual task in patients with Alzheimer-type dementia. Neurobiol Aging (1993) 1.09
Sulcal variability in the Alzheimer's brain: correlations with cognition. Neurology (1998) 1.03
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (1993) 33.32
Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci U S A (1992) 16.64
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A (1993) 15.04
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology (1993) 14.54
Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science (2009) 13.45
Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr (1998) 12.47
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med (1994) 8.03
Cortical mechanisms of human imitation. Science (1999) 7.89
Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 7.51
Assessing the significance of focal activations using their spatial extent. Hum Brain Mapp (1994) 7.28
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet (1994) 7.07
Functional mapping of the human visual cortex by magnetic resonance imaging. Science (1991) 6.93
Sexual transmission of HIV. N Engl J Med (1997) 6.84
Automated image registration: II. Intersubject validation of linear and nonlinear models. J Comput Assist Tomogr (1998) 6.75
Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr (1992) 6.39
MRI-PET registration with automated algorithm. J Comput Assist Tomogr (1993) 5.96
Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol (1998) 5.93
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A (1993) 5.68
Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet (1996) 5.15
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13
Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS (2000) 4.91
Positron emission tomography study of human brain functional development. Ann Neurol (1987) 4.89
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A (1993) 4.86
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.85
Area V5 of the human brain: evidence from a combined study using positron emission tomography and magnetic resonance imaging. Cereb Cortex (1993) 4.79
Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS (2001) 4.76
Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment. Nature (1985) 4.62
Modulating emotional responses: effects of a neocortical network on the limbic system. Neuroreport (2000) 4.50
Optic nerve decompression may improve the progressive form of nonarteritic ischemic optic neuropathy. Arch Ophthalmol (1989) 4.48
Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol (2009) 4.40
Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J Virol (1999) 4.16
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA (1995) 4.02
Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA (1997) 4.00
Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenomics J (2006) 3.92
Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell (1987) 3.60
SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am J Hum Genet (2000) 3.58
High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa. J Infect Dis (1998) 3.46
Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N Engl J Med (1991) 3.45
Effect of antiviral treatment on the shedding of HIV-1 in semen. AIDS (1997) 3.42
The microbicidal mechanisms of human neutrophils and eosinophils. Rev Infect Dis (1981) 3.29
Automated labeling of the human brain: a preliminary report on the development and evaluation of a forward-transform method. Hum Brain Mapp (1997) 3.23
Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. N Engl J Med (1998) 3.23
Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis (1999) 3.12
Mechanism of the luminol-dependent chemiluminescence of human neutrophils. J Immunol (1982) 3.11
A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat Genet (1996) 2.98
Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol (1998) 2.92
Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA (2001) 2.79
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. Am J Geriatr Psychiatry (2001) 2.74
Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. JAMA (1995) 2.71
Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry (1989) 2.67
Preventing sexual transmission of HIV--new ideas from sub-Saharan Africa. N Engl J Med (2000) 2.67
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J (2009) 2.66
Sexual transmission of HIV: infectiousness and prevention. AIDS (1999) 2.59
Linkage of Charcot-Marie-Tooth neuropathy type 1a to chromosome 17. Exp Neurol (1989) 2.58
Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS (1997) 2.51
Bacterial adaptation to oxidative stress: implications for pathogenesis and interaction with phagocytic cells. FASEB J (1989) 2.47
Trichomoniasis: clinical manifestations, diagnosis and management. Sex Transm Infect (2004) 2.43
Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. JAMA (2001) 2.36
A new probe for the diagnosis of myotonic muscular dystrophy. Science (1987) 2.35
The transferrin receptor expressed by gonococcal strain FA1090 is required for the experimental infection of human male volunteers. Mol Microbiol (1998) 2.33
Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. Am J Med (1981) 2.31
Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry (1992) 2.31
Fine mapping of autistic disorder to chromosome 15q11-q13 by use of phenotypic subtypes. Am J Hum Genet (2003) 2.23
Functional cerebral imaging by susceptibility-contrast NMR. Magn Reson Med (1990) 2.14
Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative culture. J Virol Methods (1996) 2.12
Response of Pseudomonas aeruginosa to pyocyanin: mechanisms of resistance, antioxidant defenses, and demonstration of a manganese-cofactored superoxide dismutase. Infect Immun (1992) 2.09
Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. JAMA (2000) 2.08
Closed reduction and percutaneous pinning of fractures of the proximal phalanx. J Hand Surg Br (2001) 2.07
ApoE genotype and survival from intracerebral haemorrhage. Lancet (1995) 2.07
Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism. Am J Hum Genet (2005) 2.06
Genotype-based association test for general pedigrees: the genotype-PDT. Genet Epidemiol (2003) 2.06
Creation and use of a Talairach-compatible atlas for accurate, automated, nonlinear intersubject registration, and analysis of functional imaging data. Hum Brain Mapp (1999) 2.03
HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet (2003) 2.02
An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease. Nat Genet (1999) 2.01
Mapping motor representations with positron emission tomography. Nature (1994) 2.00
Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry (1987) 1.98
Genetic studies of autistic disorder and chromosome 7. Genomics (1999) 1.94
Multiple gonococcal pilin antigenic variants are produced during experimental human infections. J Clin Invest (1994) 1.93
Positron emission tomography: human brain function and biochemistry. Science (1985) 1.92
Qualitative and quantitative evaluation of six algorithms for correcting intensity nonuniformity effects. Neuroimage (2001) 1.90
Brain parenchyma motion: measurement with cine echo-planar MR imaging. Radiology (1992) 1.90
Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. Clin Infect Dis (2000) 1.89
Genome-wide association study of Alzheimer's disease. Transl Psychiatry (2012) 1.88
Linkage of Tunisian autosomal recessive Duchenne-like muscular dystrophy to the pericentromeric region of chromosome 13q. Nat Genet (1992) 1.87